Skip to main content
Top

Drugs

Issue 4/2016

Content (8 Articles)

Pharmacotherapy for Fragile X Syndrome: Progress to Date

  • Leading Article

Matthew H. Davenport, Tori L. Schaefer, Katherine J. Friedmann, Sarah E. Fitzpatrick, Craig A. Erickson

Therapeutic Strategies for the Treatment of Severe Cushing’s Syndrome

  • Therapy in Practice

Krystallenia I. Alexandraki, Ashley B. Grossman

Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives

  • Open Access
  • Review Article

César Magro-Checa, Elisabeth J. Zirkzee, Tom W. Huizinga, Gerda M. Steup-Beekman

Dichlorphenamide: A Review in Primary Periodic Paralyses

  • Adis Drug Evaluation

Sarah L. Greig

Lesinurad: First Global Approval

  • AdisInsight Report

Sheridan M. Hoy

Brivaracetam: First Global Approval

  • AdisInsight Report

Anthony Markham

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images